4I41

Crystal Structure of human Ser/Thr kinase Pim1 in complex with mitoxantrone

4I41 の概要

• エントリーDOI: 10.2210/pdb4i41/pdb
• 分子名称: Serine/threonine-protein kinase pim-1, 1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)-9,10-ANTHRACENEDIONE (3 entities in total)
• 機能のキーワード: ser/thr kinase, mitoxantrone, transferase-transferase inhibitor complex, transferase/transferase inhibitor
• 由来する生物種: Homo sapiens (human)
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 33426.83

構造登録者

Zhang, W.,Wan, X.,Xie, Y.,Huang, N. (登録日: 2012-11-27, 公開日: 2013-12-11, 最終更新日: 2024-11-27)

主引用文献

Wan, X.,Zhang, W.,Li, L.,Xie, Y.,Li, W.,Huang, N.
A new target for an old drug: identifying mitoxantrone as a nanomolar inhibitor of PIM1 kinase via kinome-wide selectivity modeling.
J. Med. Chem., 56:2619-2629, 2013

PubMed Abstract: The rational design of selective kinase inhibitors remains a great challenge. Here we describe a physics-based approach to computationally modeling the kinase inhibitor selectivity profile. We retrospectively assessed this protocol by computing the binding profiles of 17 well-known kinase inhibitors against 143 kinases. Next, we predicted the binding profile of the chemotherapy drug mitoxantrone, and chose the predicted top five kinase targets for in vitro kinase assays. Remarkably, mitoxantrone was shown to possess low nanomolar inhibitory activity against PIM1 kinase and to inhibit the PIM1-mediated phosphorylation in cancer cells. We further determined the crystal complex structure of PIM1 bound with mitoxantrone, which reveals the structural and mechanistic basis for a novel mode of PIM1 inhibition. Although mitoxantrone's mechanism of action had been originally thought to act through DNA intercalation and type II topoisomerase inhibition, we hypothesize that PIM1 kinase inhibition might also contribute to mitoxantrone's therapeutic efficacy and specificity.

PubMed: 23442188
DOI: 10.1021/jm400045y

実験手法

X-RAY DIFFRACTION (2.7 Å)